Not applicableUnknownNCT04836598What this trial is testingBikini Scarless Laparoscopic Cholecystectomy for Morbid Obesity as a Day Case.Who this might be right forCholecystitis, Chronic Zagazig University 3
Not applicableEnded earlyNCT00253552What this trial is testingG-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic DisordersWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more OHSU Knight Cancer Institute 4
Testing effectiveness (Phase 2)Study completedNCT00686855What this trial is testingTopical Dexamethasone and Tacrolimus for the Treatment of Oral Chronic Graft-Versus-Host DiseaseWho this might be right forOral Chronic Graft-versus-host Disease Brigham and Women's Hospital 46
Testing effectiveness (Phase 2)Study completedNCT00003335What this trial is testingUmbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic CancerWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+2 more Case Comprehensive Cancer Center 44
Early research (Phase 1)Study completedNCT02611063What this trial is testingEvaluation of Fostamatinib in Patients With cGVHD After Allogeneic Stem Cell TransplantWho this might be right forHematological Malignancies Stefanie Sarantopoulos, MD, PhD. 22
Not applicableStudy completedNCT03602599What this trial is testingChronic Graft-versus-Host Disease in the Oral Cavity of Patients Following Allogeneic Hematopoietic Stem Cell Transplant and Including Healthy ControlsWho this might be right forGraft Versus Host Disease National Institute of Dental and Craniofacial Research (NIDCR) 190
Testing effectiveness (Phase 2)UnknownNCT04692376What this trial is testingMSC for Treatment of cGVHD After Allo-HSCTWho this might be right forChronic Graft-versus-host Disease Nanfang Hospital, Southern Medical University 152
Testing effectiveness (Phase 2)Study completedNCT01309997What this trial is testingImatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host DiseaseWho this might be right forGraft Versus Host DiseaseSystemic Scleroderma Lee, Stephanie 72
Large-scale testing (Phase 3)Active Not RecruitingNCT06143891What this trial is testingTest an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease.Who this might be right forChronic Graft Versus Host Disease Sanofi 260
Testing effectiveness (Phase 2)UnknownNCT01240525What this trial is testingDonor Lymphocyte Infusion After Stem Cell Transplant in Treating Patients With Haematological CancersWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+2 more University College, London 114
Not applicableEnded earlyNCT00608517What this trial is testingTreatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate MofetilWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+2 more Vanderbilt-Ingram Cancer Center 6
Not applicableUnknownNCT05723224What this trial is testingElective Endoscopic Gallbladder Treatment: Pilot StudyWho this might be right forCholecystolithiasisCholecystitis, Chronic Fondazione Policlinico Universitario Agostino Gemelli IRCCS 20
Large-scale testing (Phase 3)WithdrawnNCT00349518What this trial is testingStudy of Dasatinib in Imatinib Resistant or Intolerant Subjects With Chronic or Advanced Phase CML or Philadelphia Chromosome Positive ALLWho this might be right forChronic Myeloid LeukemiaAcute Lymphoblastic Leukemia Bristol-Myers Squibb
Not applicableUnknownNCT05692713What this trial is testingPolyomic Biomarker Verification in Adult Chronic Graft-Versus-Host Disease (ABLE3.0/CTTC2201)Who this might be right forChronic Graft-versus-Host-DiseaseAllogeneic Hematopoietic Stem Cell TransplantationLeukemia+2 more University of British Columbia 320
Testing effectiveness (Phase 2)Looking for participantsNCT06619561What this trial is testingEvaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)Who this might be right forChronic Graft-Versus-Host Disease (cGVHD) Deciphera Pharmaceuticals, LLC 48
Not applicableUnknownNCT05355675What this trial is testingThe Association of Microbiota Composition With cGVHD After Allo-HSCTWho this might be right forHematopoietic Stem Cell TransplantationHematologic MalignancyChronic Graft-versus-host-disease+1 more First Affiliated Hospital of Zhejiang University 300
Testing effectiveness (Phase 2)Study completedNCT01251575What this trial is testingSirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell TransplantWho this might be right forAdult Acute Lymphoblastic LeukemiaAdult Acute Myeloid LeukemiaAdult Diffuse Large B-Cell Lymphoma+21 more Fred Hutchinson Cancer Center 77
Early research (Phase 1)Ended earlyNCT00376519What this trial is testingUmbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic DiseasesWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+3 more Masonic Cancer Center, University of Minnesota 3
Testing effectiveness (Phase 2)Looking for participantsNCT05327023What this trial is testingDonor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic MalignanciesWho this might be right forHematologic Neoplasms National Cancer Institute (NCI) 430
Testing effectiveness (Phase 2)Study completedNCT02997280What this trial is testingRuxolitinib for Steroid-refractory GVHDWho this might be right forGraft Vs Host Disease St. Petersburg State Pavlov Medical University 75